← Back to Clinical Trials
Recruiting NCT06940284

NCT06940284 Food Intake of Hospitalized Elderly and Its Influence on Muscular and Clinical Outcomes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06940284
Status Recruiting
Phase
Sponsor University of Sao Paulo General Hospital
Condition Atrophy, Muscular
Study Type OBSERVATIONAL
Enrollment 60 participants
Start Date 2025-05-01
Primary Completion 2026-01-30

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 60 participants in total. It began in 2025-05-01 with a primary completion date of 2026-01-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The objectives of the present study are: 1) to characterize the energy-protein intake of the elderly during hospitalization; 2) to verify the influence of energy-protein intake during hospitalization on muscular (i.e., cross-sectional area of the rectus femoris and vastus lateralis muscles, muscle strength, functionality and level of independence) and clinical (i.e., length of hospital stay, hospital readmission and mortality) at the time of hospital discharge, 2 and 6 months after hospital discharge and; 3) to verify whether energy-protein intake during hospitalization is a significant predictor of loss of function and muscle mass, length of hospital stay, hospital readmission rate and mortality.

Eligibility Criteria

Inclusion Criteria: * both sex; * 65 years and older; * hospital stay less than 48 hours; Exclusion Criteria: * cancer in the last 5 years; * delirium; * cognitive deficit that impossibility the patient to read and sign the informed consent form; * neurological disease; * neurodegenerative muscular disease; * patients receive nutrition via enteral and parenteral routes.

Contact & Investigator

Central Contact

Hamilton Roschel, PhD

✉ hars@usp.br

📞 +551130618789

Principal Investigator

Hamilton Roschel, PhD

PRINCIPAL INVESTIGATOR

University of Sao Paulo General Hospital

Frequently Asked Questions

Who can join the NCT06940284 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, studying Atrophy, Muscular. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06940284 currently recruiting?

Yes, NCT06940284 is actively recruiting participants. Contact the research team at hars@usp.br for enrollment information.

Where is the NCT06940284 trial being conducted?

This trial is being conducted at São Paulo, Brazil.

Who is sponsoring the NCT06940284 clinical trial?

NCT06940284 is sponsored by University of Sao Paulo General Hospital. The principal investigator is Hamilton Roschel, PhD at University of Sao Paulo General Hospital. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology